Chemoradiotherapy With or Without Sintilimab in Limited-stage SCLC

Clinical trial NCT04189094 · UNKNOWN

Trial details

NCT number: NCT04189094
Sponsor: Zhejiang Cancer Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Cancer Limited Stage

Start date: 2020-01-01
Primary completion: 2021-07-01
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.